Simplex Trading’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.1K | Sell |
4,866
-11,570
| -70% | -$21.4K | ﹤0.01% | 7465 |
|
|
2026
Q1 | $19.7K | Buy |
16,436
+14,807
| +909% | +$18K | ﹤0.01% | 6794 |
|
|
2025
Q4 | $1.6K | Buy |
+1,629
| New | +$1.96K | ﹤0.01% | 7902 |
|
|
2025
Q3 | – | Sell |
-38,019
| Closed | -$41K | – | 9329 |
|
|
2025
Q2 | $42K | Buy |
38,019
+23,639
| +164% | +$27.5K | ﹤0.01% | 6095 |
|
|
2025
Q1 | $11K | Buy |
+14,380
| New | +$17.6K | ﹤0.01% | 7024 |
|
|
2024
Q4 | – | Sell |
-178
| Closed | -$449 | – | 8823 |
|
|
2024
Q3 | $0 | Sell |
178
-1,304
| -88% | -$5.07K | ﹤0.01% | 8795 |
|
|
2024
Q2 | $4K | Sell |
1,482
-138
| -9% | -$604 | ﹤0.01% | 7977 |
|
|
2024
Q1 | $11K | Buy |
1,620
+171
| +12% | +$1.06K | ﹤0.01% | 7537 |
|
|
2023
Q4 | $5K | Buy |
1,449
+1,130
| +354% | +$2.67K | ﹤0.01% | 7846 |
|
|
2023
Q3 | $0 | Sell |
319
-9,122
| -97% | -$30.2K | ﹤0.01% | 8978 |
|
|
2023
Q2 | $44K | Sell |
9,441
-895
| -9% | -$4.94K | ﹤0.01% | 5962 |
|
|
2023
Q1 | $58K | Buy |
10,336
+8,832
| +587% | +$53.3K | ﹤0.01% | 5756 |
|
|
2022
Q4 | $15K | Buy |
1,504
+139
| +10% | +$2.61K | ﹤0.01% | 7136 |
|
|
2022
Q3 | $30K | Buy |
1,365
+1,192
| +689% | +$34.4K | ﹤0.01% | 7072 |
|
|
2022
Q2 | $4K | Sell |
173
-10,244
| -98% | -$283K | ﹤0.01% | 8954 |
|
|
2022
Q1 | $403K | Buy |
10,417
+9,991
| +2,345% | +$387K | ﹤0.01% | 4128 |
|
|
2021
Q4 | $24K | Buy |
+426
| New | +$24.1K | ﹤0.01% | 8147 |
|
|
2020
Q4 | – | Sell |
-19,284
| Closed | -$1.2M | – | 8542 |
|
|
2020
Q3 | $770K | Buy |
+19,284
| New | +$673K | ﹤0.01% | 2534 |
|
|
2020
Q1 | – | Sell |
-1,579
| Closed | -$39.9K | – | 7764 |
|
|
2019
Q4 | $30K | Sell |
1,579
-8,809
| -85% | -$140K | ﹤0.01% | 5650 |
|
|
2019
Q3 | $161K | Sell |
10,388
-342
| -3% | -$6.56K | ﹤0.01% | 3793 |
|
|
2019
Q2 | $217K | Sell |
10,730
-7,683
| -42% | -$138K | ﹤0.01% | 3385 |
|
|
2019
Q1 | $323K | Buy |
18,413
+10,019
| +119% | +$158K | ﹤0.01% | 3114 |
|
|
2018
Q4 | $107K | Buy |
8,394
+8,280
| +7,263% | +$115K | ﹤0.01% | 3801 |
|
|
2018
Q3 | $1K | Sell |
114
-13,051
| -99% | -$154K | ﹤0.01% | 7181 |
|
|
2018
Q2 | $149K | Sell |
13,165
-16,297
| -55% | -$180K | ﹤0.01% | 3820 |
|
|
2018
Q1 | $287K | Buy |
29,462
+25,468
| +638% | +$244K | 0.01% | 1009 |
|
|
2017
Q4 | $24K | Buy |
3,994
+3,890
| +3,740% | +$17.4K | ﹤0.01% | 3125 |
|
|
2017
Q3 | $0 | Buy |
+104
| New | +$354 | ﹤0.01% | 6082 |
|
Other funds holding FATE
RG
JJ
Simplex Trading's FATE Position: Q2 2026 in Review
Simplex Trading reduced its Fate Therapeutics (FATE) stake by 70% in Q2 2026, selling an estimated $21.4K and leaving 4,866 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #7465.
Simplex Trading first reported a position in FATE in Q3 2017 and has held it in 28 quarters since. The position peaked at $770K in Q3 2020. 156 funds tracked by Wall St. Rank hold FATE as of Q2 2026.
- Simplex Trading held 4,866 shares of Fate Therapeutics worth $13.1K as of Q2 2026.
- Simplex Trading sold 11,570 Fate Therapeutics shares in Q2 2026, an estimated $21.4K.
- Fate Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7465 holding.
- Simplex Trading first reported a position in Fate Therapeutics in Q3 2017 and has held it in 28 quarters since.
- Simplex Trading's Fate Therapeutics position peaked at $770K in Q3 2020.
- 156 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.